Submenu
- RCMB Planning Committee
- RCMB Program Committee
- Early Career Professionals Working Group
- RCMB Stem Cell Working Group
- RCMB Website Committee
- Metabolomics and Proteomics Working Group
Working Groups
RCMB Stem Cell Working Group
Chair
Robert Freishtat, MD
The Stem Cell Working Group is comprised of physicians, researchers, and others interested in exploring the possibilities offered by recent exciting promise in the areas of lung stem cells, cell therapies for lung diseases, and in bioengineering functional new lungs that can be used in transplantation. Particular focus areas for the working group are promotion of research, funding, education, and public awareness of these rapidly developing areas. The working group is also active in educating patients, families, and caregivers on the growing problem of stem cell medical tourism and has forged links between the ATS and prominent stem cell research and clinical foundations to help combat this.
- Unproven Stem Cell Treatments for Lung Disease -- An Emerging Public Health Problem
- The Global Emergence of Unregulated Stem Cell Treatments for Respiratory Diseases
- FDA’s Draft Guidances Relating to the Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products
- Statement on Unproven Stem Cell Interventions for Lung Diseases
- Stem Cells and Cell Therapies for Lung Diseases
- 2016 Working Group Annual Report
- Statement by the Research Advisory Committee Working Group in response to proposed changes in the clinicaltrials.gov website
- Webinar: Introduction to Mesenchymal Stem Cell (January 29, 2014)
- Working Group Members
Last Reviewed: April 2017
